The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Pet Drug and Vaccine Market Research Report 2025
Synopsis
In this report, we study the Veterinary Products for Companion Animals mainly medicines, vaccines and others.
The global Pet Drug and Vaccine market was valued at US$ 15280 million in 2023 and is anticipated to reach US$ 24530 million by 2030, witnessing a CAGR of 7.0% during the forecast period 2024-2030.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 458%.
This report aims to provide a comprehensive presentation of the global market for Pet Drug and Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pet Drug and Vaccine.
Report Scope
The Pet Drug and Vaccine market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pet Drug and Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pet Drug and Vaccine companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Zoetis
Boehringer Ingelheim
Merck Animal Health
Elanco Animal Health
Virbac
Dechra Veterinary Products
Ceva
Vetoquinol
Meiji
Ouro Fino Saude
Parnell
Segment by Type
Drugs
Vaccine
Segment by Application
Dogs
Cats
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pet Drug and Vaccine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
In this report, we study the Veterinary Products for Companion Animals mainly medicines, vaccines and others.
The global Pet Drug and Vaccine market was valued at US$ 15280 million in 2023 and is anticipated to reach US$ 24530 million by 2030, witnessing a CAGR of 7.0% during the forecast period 2024-2030.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 458%.
This report aims to provide a comprehensive presentation of the global market for Pet Drug and Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pet Drug and Vaccine.
Report Scope
The Pet Drug and Vaccine market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pet Drug and Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pet Drug and Vaccine companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Zoetis
Boehringer Ingelheim
Merck Animal Health
Elanco Animal Health
Virbac
Dechra Veterinary Products
Ceva
Vetoquinol
Meiji
Ouro Fino Saude
Parnell
Segment by Type
Drugs
Vaccine
Segment by Application
Dogs
Cats
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pet Drug and Vaccine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pet Drug and Vaccine Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Drugs
1.2.3 Vaccine
1.3 Market by Application
1.3.1 Global Pet Drug and Vaccine Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Dogs
1.3.3 Cats
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pet Drug and Vaccine Market Perspective (2019-2030)
2.2 Pet Drug and Vaccine Growth Trends by Region
2.2.1 Global Pet Drug and Vaccine Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Pet Drug and Vaccine Historic Market Size by Region (2019-2024)
2.2.3 Pet Drug and Vaccine Forecasted Market Size by Region (2025-2030)
2.3 Pet Drug and Vaccine Market Dynamics
2.3.1 Pet Drug and Vaccine Industry Trends
2.3.2 Pet Drug and Vaccine Market Drivers
2.3.3 Pet Drug and Vaccine Market Challenges
2.3.4 Pet Drug and Vaccine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pet Drug and Vaccine Players by Revenue
3.1.1 Global Top Pet Drug and Vaccine Players by Revenue (2019-2024)
3.1.2 Global Pet Drug and Vaccine Revenue Market Share by Players (2019-2024)
3.2 Global Pet Drug and Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pet Drug and Vaccine Revenue
3.4 Global Pet Drug and Vaccine Market Concentration Ratio
3.4.1 Global Pet Drug and Vaccine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pet Drug and Vaccine Revenue in 2023
3.5 Pet Drug and Vaccine Key Players Head office and Area Served
3.6 Key Players Pet Drug and Vaccine Product Solution and Service
3.7 Date of Enter into Pet Drug and Vaccine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pet Drug and Vaccine Breakdown Data by Type
4.1 Global Pet Drug and Vaccine Historic Market Size by Type (2019-2024)
4.2 Global Pet Drug and Vaccine Forecasted Market Size by Type (2025-2030)
5 Pet Drug and Vaccine Breakdown Data by Application
5.1 Global Pet Drug and Vaccine Historic Market Size by Application (2019-2024)
5.2 Global Pet Drug and Vaccine Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Pet Drug and Vaccine Market Size (2019-2030)
6.2 North America Pet Drug and Vaccine Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Pet Drug and Vaccine Market Size by Country (2019-2024)
6.4 North America Pet Drug and Vaccine Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pet Drug and Vaccine Market Size (2019-2030)
7.2 Europe Pet Drug and Vaccine Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Pet Drug and Vaccine Market Size by Country (2019-2024)
7.4 Europe Pet Drug and Vaccine Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pet Drug and Vaccine Market Size (2019-2030)
8.2 Asia-Pacific Pet Drug and Vaccine Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Pet Drug and Vaccine Market Size by Region (2019-2024)
8.4 Asia-Pacific Pet Drug and Vaccine Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pet Drug and Vaccine Market Size (2019-2030)
9.2 Latin America Pet Drug and Vaccine Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Pet Drug and Vaccine Market Size by Country (2019-2024)
9.4 Latin America Pet Drug and Vaccine Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pet Drug and Vaccine Market Size (2019-2030)
10.2 Middle East & Africa Pet Drug and Vaccine Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Pet Drug and Vaccine Market Size by Country (2019-2024)
10.4 Middle East & Africa Pet Drug and Vaccine Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Zoetis
11.1.1 Zoetis Company Detail
11.1.2 Zoetis Business Overview
11.1.3 Zoetis Pet Drug and Vaccine Introduction
11.1.4 Zoetis Revenue in Pet Drug and Vaccine Business (2019-2024)
11.1.5 Zoetis Recent Development
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Detail
11.2.2 Boehringer Ingelheim Business Overview
11.2.3 Boehringer Ingelheim Pet Drug and Vaccine Introduction
11.2.4 Boehringer Ingelheim Revenue in Pet Drug and Vaccine Business (2019-2024)
11.2.5 Boehringer Ingelheim Recent Development
11.3 Merck Animal Health
11.3.1 Merck Animal Health Company Detail
11.3.2 Merck Animal Health Business Overview
11.3.3 Merck Animal Health Pet Drug and Vaccine Introduction
11.3.4 Merck Animal Health Revenue in Pet Drug and Vaccine Business (2019-2024)
11.3.5 Merck Animal Health Recent Development
11.4 Elanco Animal Health
11.4.1 Elanco Animal Health Company Detail
11.4.2 Elanco Animal Health Business Overview
11.4.3 Elanco Animal Health Pet Drug and Vaccine Introduction
11.4.4 Elanco Animal Health Revenue in Pet Drug and Vaccine Business (2019-2024)
11.4.5 Elanco Animal Health Recent Development
11.5 Virbac
11.5.1 Virbac Company Detail
11.5.2 Virbac Business Overview
11.5.3 Virbac Pet Drug and Vaccine Introduction
11.5.4 Virbac Revenue in Pet Drug and Vaccine Business (2019-2024)
11.5.5 Virbac Recent Development
11.6 Dechra Veterinary Products
11.6.1 Dechra Veterinary Products Company Detail
11.6.2 Dechra Veterinary Products Business Overview
11.6.3 Dechra Veterinary Products Pet Drug and Vaccine Introduction
11.6.4 Dechra Veterinary Products Revenue in Pet Drug and Vaccine Business (2019-2024)
11.6.5 Dechra Veterinary Products Recent Development
11.7 Ceva
11.7.1 Ceva Company Detail
11.7.2 Ceva Business Overview
11.7.3 Ceva Pet Drug and Vaccine Introduction
11.7.4 Ceva Revenue in Pet Drug and Vaccine Business (2019-2024)
11.7.5 Ceva Recent Development
11.8 Vetoquinol
11.8.1 Vetoquinol Company Detail
11.8.2 Vetoquinol Business Overview
11.8.3 Vetoquinol Pet Drug and Vaccine Introduction
11.8.4 Vetoquinol Revenue in Pet Drug and Vaccine Business (2019-2024)
11.8.5 Vetoquinol Recent Development
11.9 Meiji
11.9.1 Meiji Company Detail
11.9.2 Meiji Business Overview
11.9.3 Meiji Pet Drug and Vaccine Introduction
11.9.4 Meiji Revenue in Pet Drug and Vaccine Business (2019-2024)
11.9.5 Meiji Recent Development
11.10 Ouro Fino Saude
11.10.1 Ouro Fino Saude Company Detail
11.10.2 Ouro Fino Saude Business Overview
11.10.3 Ouro Fino Saude Pet Drug and Vaccine Introduction
11.10.4 Ouro Fino Saude Revenue in Pet Drug and Vaccine Business (2019-2024)
11.10.5 Ouro Fino Saude Recent Development
11.11 Parnell
11.11.1 Parnell Company Detail
11.11.2 Parnell Business Overview
11.11.3 Parnell Pet Drug and Vaccine Introduction
11.11.4 Parnell Revenue in Pet Drug and Vaccine Business (2019-2024)
11.11.5 Parnell Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Pet Drug and Vaccine Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Drugs
Table 3. Key Players of Vaccine
Table 4. Global Pet Drug and Vaccine Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Pet Drug and Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Pet Drug and Vaccine Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Pet Drug and Vaccine Market Share by Region (2019-2024)
Table 8. Global Pet Drug and Vaccine Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Pet Drug and Vaccine Market Share by Region (2025-2030)
Table 10. Pet Drug and Vaccine Market Trends
Table 11. Pet Drug and Vaccine Market Drivers
Table 12. Pet Drug and Vaccine Market Challenges
Table 13. Pet Drug and Vaccine Market Restraints
Table 14. Global Pet Drug and Vaccine Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Pet Drug and Vaccine Market Share by Players (2019-2024)
Table 16. Global Top Pet Drug and Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Drug and Vaccine as of 2023)
Table 17. Ranking of Global Top Pet Drug and Vaccine Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Pet Drug and Vaccine Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Pet Drug and Vaccine Product Solution and Service
Table 21. Date of Enter into Pet Drug and Vaccine Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Pet Drug and Vaccine Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Pet Drug and Vaccine Revenue Market Share by Type (2019-2024)
Table 25. Global Pet Drug and Vaccine Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Pet Drug and Vaccine Revenue Market Share by Type (2025-2030)
Table 27. Global Pet Drug and Vaccine Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Pet Drug and Vaccine Revenue Market Share by Application (2019-2024)
Table 29. Global Pet Drug and Vaccine Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Pet Drug and Vaccine Revenue Market Share by Application (2025-2030)
Table 31. North America Pet Drug and Vaccine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Pet Drug and Vaccine Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Pet Drug and Vaccine Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Pet Drug and Vaccine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Pet Drug and Vaccine Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Pet Drug and Vaccine Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Pet Drug and Vaccine Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Pet Drug and Vaccine Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Pet Drug and Vaccine Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Pet Drug and Vaccine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Pet Drug and Vaccine Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Pet Drug and Vaccine Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Pet Drug and Vaccine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Pet Drug and Vaccine Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Pet Drug and Vaccine Market Size by Country (2025-2030) & (US$ Million)
Table 46. Zoetis Company Detail
Table 47. Zoetis Business Overview
Table 48. Zoetis Pet Drug and Vaccine Product
Table 49. Zoetis Revenue in Pet Drug and Vaccine Business (2019-2024) & (US$ Million)
Table 50. Zoetis Recent Development
Table 51. Boehringer Ingelheim Company Detail
Table 52. Boehringer Ingelheim Business Overview
Table 53. Boehringer Ingelheim Pet Drug and Vaccine Product
Table 54. Boehringer Ingelheim Revenue in Pet Drug and Vaccine Business (2019-2024) & (US$ Million)
Table 55. Boehringer Ingelheim Recent Development
Table 56. Merck Animal Health Company Detail
Table 57. Merck Animal Health Business Overview
Table 58. Merck Animal Health Pet Drug and Vaccine Product
Table 59. Merck Animal Health Revenue in Pet Drug and Vaccine Business (2019-2024) & (US$ Million)
Table 60. Merck Animal Health Recent Development
Table 61. Elanco Animal Health Company Detail
Table 62. Elanco Animal Health Business Overview
Table 63. Elanco Animal Health Pet Drug and Vaccine Product
Table 64. Elanco Animal Health Revenue in Pet Drug and Vaccine Business (2019-2024) & (US$ Million)
Table 65. Elanco Animal Health Recent Development
Table 66. Virbac Company Detail
Table 67. Virbac Business Overview
Table 68. Virbac Pet Drug and Vaccine Product
Table 69. Virbac Revenue in Pet Drug and Vaccine Business (2019-2024) & (US$ Million)
Table 70. Virbac Recent Development
Table 71. Dechra Veterinary Products Company Detail
Table 72. Dechra Veterinary Products Business Overview
Table 73. Dechra Veterinary Products Pet Drug and Vaccine Product
Table 74. Dechra Veterinary Products Revenue in Pet Drug and Vaccine Business (2019-2024) & (US$ Million)
Table 75. Dechra Veterinary Products Recent Development
Table 76. Ceva Company Detail
Table 77. Ceva Business Overview
Table 78. Ceva Pet Drug and Vaccine Product
Table 79. Ceva Revenue in Pet Drug and Vaccine Business (2019-2024) & (US$ Million)
Table 80. Ceva Recent Development
Table 81. Vetoquinol Company Detail
Table 82. Vetoquinol Business Overview
Table 83. Vetoquinol Pet Drug and Vaccine Product
Table 84. Vetoquinol Revenue in Pet Drug and Vaccine Business (2019-2024) & (US$ Million)
Table 85. Vetoquinol Recent Development
Table 86. Meiji Company Detail
Table 87. Meiji Business Overview
Table 88. Meiji Pet Drug and Vaccine Product
Table 89. Meiji Revenue in Pet Drug and Vaccine Business (2019-2024) & (US$ Million)
Table 90. Meiji Recent Development
Table 91. Ouro Fino Saude Company Detail
Table 92. Ouro Fino Saude Business Overview
Table 93. Ouro Fino Saude Pet Drug and Vaccine Product
Table 94. Ouro Fino Saude Revenue in Pet Drug and Vaccine Business (2019-2024) & (US$ Million)
Table 95. Ouro Fino Saude Recent Development
Table 96. Parnell Company Detail
Table 97. Parnell Business Overview
Table 98. Parnell Pet Drug and Vaccine Product
Table 99. Parnell Revenue in Pet Drug and Vaccine Business (2019-2024) & (US$ Million)
Table 100. Parnell Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pet Drug and Vaccine Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Pet Drug and Vaccine Market Share by Type: 2023 VS 2030
Figure 3. Drugs Features
Figure 4. Vaccine Features
Figure 5. Global Pet Drug and Vaccine Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Pet Drug and Vaccine Market Share by Application: 2023 VS 2030
Figure 7. Dogs Case Studies
Figure 8. Cats Case Studies
Figure 9. Other Case Studies
Figure 10. Pet Drug and Vaccine Report Years Considered
Figure 11. Global Pet Drug and Vaccine Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Pet Drug and Vaccine Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Pet Drug and Vaccine Market Share by Region: 2023 VS 2030
Figure 14. Global Pet Drug and Vaccine Market Share by Players in 2023
Figure 15. Global Top Pet Drug and Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Drug and Vaccine as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Pet Drug and Vaccine Revenue in 2023
Figure 17. North America Pet Drug and Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Pet Drug and Vaccine Market Share by Country (2019-2030)
Figure 19. United States Pet Drug and Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Pet Drug and Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Pet Drug and Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Pet Drug and Vaccine Market Share by Country (2019-2030)
Figure 23. Germany Pet Drug and Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Pet Drug and Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Pet Drug and Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Pet Drug and Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Pet Drug and Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Pet Drug and Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Pet Drug and Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Pet Drug and Vaccine Market Share by Region (2019-2030)
Figure 31. China Pet Drug and Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Pet Drug and Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Pet Drug and Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Pet Drug and Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Pet Drug and Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Pet Drug and Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Pet Drug and Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Pet Drug and Vaccine Market Share by Country (2019-2030)
Figure 39. Mexico Pet Drug and Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Pet Drug and Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Pet Drug and Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Pet Drug and Vaccine Market Share by Country (2019-2030)
Figure 43. Turkey Pet Drug and Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Pet Drug and Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Zoetis Revenue Growth Rate in Pet Drug and Vaccine Business (2019-2024)
Figure 46. Boehringer Ingelheim Revenue Growth Rate in Pet Drug and Vaccine Business (2019-2024)
Figure 47. Merck Animal Health Revenue Growth Rate in Pet Drug and Vaccine Business (2019-2024)
Figure 48. Elanco Animal Health Revenue Growth Rate in Pet Drug and Vaccine Business (2019-2024)
Figure 49. Virbac Revenue Growth Rate in Pet Drug and Vaccine Business (2019-2024)
Figure 50. Dechra Veterinary Products Revenue Growth Rate in Pet Drug and Vaccine Business (2019-2024)
Figure 51. Ceva Revenue Growth Rate in Pet Drug and Vaccine Business (2019-2024)
Figure 52. Vetoquinol Revenue Growth Rate in Pet Drug and Vaccine Business (2019-2024)
Figure 53. Meiji Revenue Growth Rate in Pet Drug and Vaccine Business (2019-2024)
Figure 54. Ouro Fino Saude Revenue Growth Rate in Pet Drug and Vaccine Business (2019-2024)
Figure 55. Parnell Revenue Growth Rate in Pet Drug and Vaccine Business (2019-2024)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
